Atossa Therapeutics (ATOS) EPS (Basic) (2011 - 2026)
Atossa Therapeutics (ATOS) posted quarterly EPS (Basic) of -$1.11 for Q1 2026, down 42.56% year-over-year from -$1.94 in Q1 2025, and up 12.44% quarter-over-quarter from -$1.27 in Q4 2025.
Atossa Therapeutics (ATOS) EPS (Basic) (2011 - 2026) Analysis & Trends
Atossa Therapeutics (ATOS) has reported EPS (Basic) for 15 consecutive years, with -$1.11 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 42.56% year-over-year to -$1.11; the TTM figure through Mar 2026 stood at -$4.37 (down 79.13% YoY), while the FY2025 annual figure was -$4.04, down 68.16% from the prior year.
- EPS (Basic) improved to -$1.11 in Q1 2026 per ATOS's latest filing, from -$1.27 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.12 in Q4 2024 and bottomed at -$1.27 in Q4 2025.
- Historically, EPS (Basic) has averaged -$0.84 across 5 years, with a median of -$0.86 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) jumped 99.86% — and 2025, when it slumped 975.4%.
- Atossa Therapeutics' EPS (Basic) stood at -$0.89 in 2022, then retreated by 3.96% to -$0.92 in 2023, then jumped by 87.2% to -$0.12 in 2024, then plunged by 975.4% to -$1.27 in 2025, then increased by 12.44% to -$1.11 in 2026.
- Business Quant data shows ATOS's EPS (Basic) at -$1.11 in Q1 2026, -$1.27 in Q4 2025, and -$1.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Atossa Therapeutics | 22.63 Mn | 22.63 Mn | - | -0.95 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.95 |
| Mar 31, 2026 | -1.11 |
| Dec 31, 2025 | -1.27 |
| Sep 30, 2025 | -1.01 |
| Jun 30, 2025 | -0.98 |
| Mar 31, 2025 | -0.78 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.86 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | -0.70 |
| Dec 31, 2023 | -0.92 |
| Sep 30, 2023 | -0.74 |
| Jun 30, 2023 | -1.16 |
| Mar 31, 2023 | -0.74 |
| Dec 31, 2022 | -0.89 |
| Sep 30, 2022 | -0.95 |
| Jun 30, 2022 | -0.79 |
| Mar 31, 2022 | -0.57 |
| Dec 31, 2021 | -619.73 |
| Sep 30, 2021 | -0.62 |